Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
October 15th, 2014
20.6K views
In cardiac myocytes, tubular membrane structures form intracellular networks. We describe optimized protocols for i) isolation of myocytes from mouse heart including quality control, ii) live cell staining for state-of-the-art fluorescence microscopy, and iii) direct image analysis to quantify the component complexity and the plasticity of intracellular membrane networks.
Overview
This article presents optimized protocols for isolating cardiac myocytes from mouse hearts and analyzing their tubular membrane networks. The methods include live cell staining and quantitative image analysis to assess the complexity and plasticity of these networks.
Key Study Components
Area of Science
- Cardiac physiology
- Cell biology
- Fluorescence microscopy
Background
- Cardiac myocytes have complex tubular membrane structures.
- Understanding these structures is crucial for insights into cardiac function.
- Live imaging techniques allow for real-time analysis of myocyte networks.
- Protocols for isolating high-quality myocytes are essential for accurate studies.
Purpose of Study
- To analyze tubular membrane networks in atrial and ventricular myocytes.
- To provide a comprehensive workflow for myocyte isolation and imaging.
- To enable quantitative analysis of membrane network differences across cell types.
Methods Used
- Isolation of myocytes from adult mouse hearts using perfusion techniques.
- Live cell staining of the transverse axial tubule system (TATS).
- Visualization using confocal or steady-state fluorescence microscopy.
- Quantitative image analysis to assess membrane network complexity.
Main Results
- Successful isolation of high-quality atrial and ventricular myocytes.
- Visualization of TATS membrane networks in living cells.
- Quantitative analysis revealed differences in membrane networks between cell types.
- The method can be applied to both healthy and diseased myocytes.
Conclusions
- The described protocols facilitate detailed analysis of cardiac myocyte membrane structures.
- Insights gained can enhance understanding of cardiac physiology and pathology.
- Training is recommended for newcomers to ensure consistent results.
Frequently Asked Questions
What is the main goal of this study?
The main goal is to analyze tubular membrane networks in cardiac myocytes.
How are the myocytes isolated?
Myocytes are isolated using a perfusion technique with digestion buffers.
What imaging techniques are used?
Confocal or steady-state fluorescence microscopy is used for imaging.
What can be analyzed using this method?
The method allows for quantitative analysis of membrane network complexity.
Is this method applicable to diseased myocytes?
Yes, it can be applied to myocytes from diseased or transgenic animals.
What training is recommended for newcomers?
Additional introductory training is recommended for consistent isolation of myocytes.
Executive Industry Relevance
Understanding the structural organization of transverse-axial tubule systems (TATS) in cardiac myocytes provides mechanistic insights into excitation-contraction coupling and calcium signaling dynamics. Quantitative analysis of TATS networks enables target de-risking by linking membrane architecture to functional phenotypes in disease models. This protocol supports preclinical assessment of cardiac phenotypes and pharmacological interventions through direct, high-throughput membrane network phenotyping.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of TATS membrane organization as a structural biomarker for cardiac functional states.
- Operational Value: Provides quantitative, reproducible readouts of tubule network density and orientation for target validation assays.
- Predictive Value: Supports mechanistic de-risking by correlating TATS structural changes with calcium handling phenotypes in disease models.
Screening & Assay Development
- Assay Readiness: Generates binarized and skeletonized TATS image data suitable for automated quantitative analysis pipelines.
- Screening Application: Enables comparison of TATS network architecture across cell types, disease states, or treatment groups in a standardized format.
- Scalability: Compatible with open-source image analysis tools for high-throughput screening of transgenic or pharmacological models.
Translational & Preclinical Research
- Translational Continuity: Links structural TATS phenotypes to functional calcium release unit (CRU) activation and intracellular signaling.
- Disease Modeling: Facilitates phenotyping of transgenic models and assessment of pathophysiological TATS remodeling in cardiac disease.
- Risk-Adjusted Advancement: Supports go/no-go decisions by quantifying membrane network alterations that predict functional deficits in cardiomyocytes.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through preclinical phenotyping by providing quantitative structural data on cardiac membrane networks.
- Discovery Biology: Supports hypothesis testing on membrane-mediated signaling pathways and calcium dynamics in cardiomyocytes.
- Screening: Enables assay-ready, reproducible imaging and analysis of TATS networks for compound or genetic perturbation studies.
- Analytics: Generates directional histograms and skeletonized metrics that quantify tubule orientation and network complexity for comparative analysis.
- Translational Research: Connects TATS structural data to downstream functional outcomes like calcium release and contractility in preclinical models.
- Enterprise Reuse: Establishes a standardized, open-access workflow for cardiac membrane phenotyping applicable across multiple projects and models.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in cardiac signaling by providing direct visualization of TATS network architecture.
- Operational Value: Ensures standardization and reproducibility through quality-controlled isolation and optimized image processing steps.
- Strategic Value: Improves predictive confidence in target selection by linking structural membrane phenotypes to functional cardiac outcomes.
- Portfolio Impact: Enables risk-stratified prioritization of compounds or genetic modifiers based on TATS network integrity and calcium handling predictions.
Implementation Considerations
- Requires expertise in cardiac myocyte isolation and live-cell membrane staining techniques.
- Dependent on confocal or super-resolution fluorescence microscopy and image analysis software (e.g., Fiji with directionality and skeletonization plugins).
- Necessitates cross-team standardization of image acquisition parameters (e.g., pixel size, Z-plane selection, threshold settings) for quantitative comparability.
- Adaptation considerations include tissue source (atrial vs. ventricular), species, and disease model compatibility with perfusion and digestion protocols.
- Practical limitations include sensitivity to cell quality and membrane integrity, requiring rigorous quality control post-isolation and pre-imaging.
Biopharma FAQs
Why does quantitative TATS network analysis matter for target validation in cardiac disease models?
Quantitative TATS analysis enables direct assessment of membrane structural changes that correlate with calcium signaling dysfunction in disease models. By measuring tubule density, orientation, and network complexity, researchers can link structural phenotypes to functional deficits in excitation-contraction coupling. This supports target validation by providing a mechanistic readout that predicts downstream calcium handling and contractile phenotypes.
How does isolation of atrial and ventricular myocytes fit into the cardiac discovery pipeline?
Isolation of primary atrial and ventricular myocytes provides a physiologically relevant system for studying chamber-specific differences in TATS organization and function. This enables target validation in a native cellular context that reflects in vivo electrophysiological and calcium handling properties. The isolated myocyte model bridges in vitro screening and intact organ physiology in the discovery pipeline.
What quantitative measurements of TATS network structure enable comparative analysis across experimental conditions?
The protocol generates binarized and skeletonized image data from which directional histograms (via FURIER component analysis) and skeleton metrics are derived. These outputs quantify the relative proportions of axial and transverse tubule components and network organization. Such measurements allow side-by-side comparison of TATS architecture between cell types, disease states, or treatment groups.
Why are replication and standardization requirements important for cross-functional collaboration in TATS analysis?
Standardized image acquisition (e.g., 100 nm pixel size, consistent Z-plane selection) and analysis parameters (e.g., threshold, block size, histogram bins) ensure reproducibility across users and laboratories. Replication confirms that observed TATS differences are biologically meaningful rather than technical artifacts. This supports reliable data sharing between discovery, preclinical, and translational teams.
What statistical and analytical capabilities are required before implementing TATS network analysis in a discovery workflow?
Implementation requires proficiency in image segmentation, background subtraction, local contrast enhancement, and skeletonization using tools like Fiji. Users must be able to apply directionality analysis (FURIER components, 180 bins, -45° start) to generate orientation histograms from skeletonized data. These capabilities enable the extraction of quantitative, statistically comparable metrics on TATS network structure and organization.
Chapters in this video
0:05
Title
1:46
Isolation of Atrial and Ventricular Myocytes from the Mouse Heart
4:09
Imaging of Transverse-axial Tubule System (TATS) Membrane Structures in Living Myocytes
5:41
Analysis of the TATS Membrane Network and its Components
8:23
Results: Representative TATS Component Orientations for Ventricular and Atrial Myocytes
9:26
Conclusion
